0000899243-22-020392.txt : 20220601
0000899243-22-020392.hdr.sgml : 20220601
20220601162127
ACCESSION NUMBER: 0000899243-22-020392
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220527
FILED AS OF DATE: 20220601
DATE AS OF CHANGE: 20220601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferenczy William J.
CENTRAL INDEX KEY: 0001812662
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 22987627
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-27
1
0000353569
QUIDEL CORP /DE/
QDEL
0001812662
Ferenczy William J.
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP, Cardio/Metabolic Unit
Common Stock
2022-05-27
4
D
0
8683
D
0
D
Non-Qualified Stock Options
23.41
2022-05-27
4
D
0
460
0.00
D
2025-02-05
Common Stock
460
0
D
Non-Qualified Stock Options
21.08
2022-05-27
4
D
0
1349
0.00
D
2027-02-15
Common Stock
1349
0
D
Non-Qualified Stock Options
46.41
2022-05-27
4
D
0
1727
0.00
D
2028-01-16
Common Stock
1727
0
D
Non-Qualified Stock Options
59.12
2022-05-27
4
D
0
3322
0.00
D
2029-02-04
Common Stock
3322
0
D
Non-Qualified Stock Options
77.16
2022-05-27
4
D
0
2609
0.00
D
2030-02-03
Common Stock
2609
0
D
Non-Qualified Stock Options
103.64
2022-05-27
4
D
0
4685
0.00
D
2030-03-30
Common Stock
4685
0
D
Non-Qualified Stock Options
254.00
2022-05-27
4
D
0
1892
0.00
D
2031-02-01
Common Stock
1892
0
D
Non-Qualified Stock Options
103.36
2022-05-27
4
D
0
4957
0.00
D
2032-01-31
Common Stock
4957
0
D
Restricted Stock Units
2022-05-27
4
D
0
1661
0.00
D
Common Stock
1661
0
D
Restricted Stock Units
2022-05-27
4
D
0
1304
0.00
D
Common Stock
1304
0
D
Restricted Stock Units
2022-05-27
4
D
0
868
0.00
D
Common Stock
868
0
D
Restricted Stock Units
2022-05-27
4
D
0
1420
0.00
D
Common Stock
1420
0
D
Restricted Stock Units
2022-05-27
4
D
0
4958
0.00
D
Common Stock
4958
0
D
Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
Vested in full.
2,492 shares are vested in full; 830 shares will vest on February 4, 2023.
1,305 shares are vested in full; the remaining 1,304 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
2,343 shares are vested in full; the remaining 2,342 shares will vest in equal installments on March 30, 2023 and March 30, 2024.
473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
1,239 shares will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025; 1,240 shares will vest on January 31, 2026.
Each restricted stock unit represents the right to receive one share of Quidel common stock.
Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
1,661 shares will vest on February 4, 2023.
1,304 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
868 shares will vest in equal installments on March 30, 2023 and March 30, 2024.
473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.
1,239 shares will vest on each of January 31, 2023 and January 31, 2024; 1,240 shares will vest on each of January 31, 2025 and January 31, 2026.
/s/ Phillip S. Askim, attorney-in-fact for William J. Ferenczy
2022-06-01